Hamasaki, S <br/><br/>
Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Mar 2000 
 - 737-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.20.3.737  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--administration & dosage<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Cholesterol, LDL--blood<br/>Coronary Circulation--physiology<br/>Coronary Disease--blood<br/>Coronary Vessels--pathology<br/>Echocardiography<br/>Endothelium, Vascular--physiology<br/>Female<br/>Humans<br/>Hypercholesterolemia--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Triglycerides--blood<br/>Ventricular Remodeling--physiology